The Treatment of Cutaneous T-cell Lymphoma with Triple Combination of Interferon alfa, Retinoid, and Photochemotherapy
Annals of Dermatology
;
: 39-41, 2004.
Artículo
en Inglés
| WPRIM
| ID: wpr-51766
ABSTRACT
Cutaneous T-cell lymphoma(CTCL) is a rare cutaneous malignant disease and is typically a disease of older adults. There is no optimal treatment for CTCL, which ranges from topical steroid to systemic chemotherapy. Hence until curative therapy is found, therapies that keep CTCL in check and prevent progression to more advanced lymphoma may be desirable alternatives and may presetve quality of life. Herein we report our experience in treating a stage 11B CTCL patient with triple combination of interferon alfa, oral retinoid, and psoralen plus WA(PWA) therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fotoquimioterapia
/
Calidad de Vida
/
Linfocitos T
/
Linfoma Cutáneo de Células T
/
Interferones
/
Interferón-alfa
/
Quimioterapia
/
Ficusina
/
Linfoma
Límite:
Adulto
/
Humanos
Idioma:
Inglés
Revista:
Annals of Dermatology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS